Clinical Trial Details
— Status: Recruiting
Administrative data
| NCT number |
NCT04664374 |
| Other study ID # |
396-2019 |
| Secondary ID |
|
| Status |
Recruiting |
| Phase |
|
| First received |
|
| Last updated |
|
| Start date |
January 6, 2020 |
| Est. completion date |
January 6, 2023 |
Study information
| Verified date |
January 2021 |
| Source |
Sunnybrook Health Sciences Centre |
| Contact |
David M Kreindler, MD |
| Phone |
416-480-6030 |
| Email |
david.kreindler[@]sunnybrook.ca |
| Is FDA regulated |
No |
| Health authority |
|
| Study type |
Observational
|
Clinical Trial Summary
MyMood is an electronic mood-charting tool available to the general population of Sunnybrook
Health Sciences Centre (SHSC). This project aims to characterize duration and frequency of
use of MyMood by users characteristics and determine if there is any significant variability
in duration and frequency of use attributable to users' age, sex, self-reported diagnosis of
a mood disorder, and/or prior treatment.
Description:
Mental Health Telemetry (MHT) is a software platform developed at Sunnybrook for collecting
real-time self-report symptom-rating questionnaire data using patients' cell phones or other
portable, Internet-enabled devices. MHT has previously been used in several funded clinical
research studies. The mood-disorders-specific version of MHT, which we have named MyMood,
collects information on a variety of items including symptom severity, medication adherence,
ER visits / hospital admissions, sleep, relationships, and life events. In our previous
project, we made MyMood available to the general population of SHSC by integrating it into
Sunnybrook's MyChart personal health record system and collected feedback from users, using
the feedback to refine MyMood. In the current project, we aim to characterize long-term
patterns of MyMood usage, examining how duration and frequency of use are affected by
demographic and clinical characteristics of users (age, sex, present / reported diagnosis of
a mood disorder, and/or prior treatment).
Please note that the _only_ route for entry into this study is self-referral: interested
individuals who have signed themselves up for MyChart can choose to begin using MyMood on
their own. There is no reason to contact the study team regarding recruitment.
